- A
bispecific monoclonal antibody (BsMAb, BsAb) is an
artificial protein that can
simultaneously bind to two
different types of
antigen or two different...
-
United States in June 2023, and in the
European Union in July 2023.
Bispecifically binds CD20 and CD3 to
engage T-cells.
Mosunetuzumab was
approved for...
-
immune response is the
class of
drugs termed bispecific T-cell
engagers (BITE), or
sometimes simply bispecific antibodies. The
first drug in this
class approved...
- Emicizumab, sold
under the
brand name Hemlibra, is a
humanized bispecific monoclonal antibody for the
treatment of
haemophilia A,
developed by Genentech...
- region, thus
obtaining a
bispecific antibody (with both Fab and Fcab
regions containing distinct binding sites).
These bispecific monoclonal antibodies are...
-
brand name Columvi, is a
bispecific monoclonal antibody used for the
treatment of
large B-cell lymphoma. It is a
bispecific CD20-directed CD3 T-cell engager...
-
medication used for the
treatment of
small cell lung cancer. It is a
bispecific T-cell
engager that
binds delta-like
ligand 3 and CD3. The most common...
- https://www.biospace.com/article/j-and-j-buys-proteologix-for-850m-secures-
bispecific-antibodies-targeting-atopic-dermatitis-/?s=79 Vecchione,
Anthony (March...
-
brand name Rybrevant, is a
bispecific monoclonal antibody used to
treat non-small cell lung cancer.
Amivantamab is a
bispecific epidermal growth factor (EGF)...
- aspect, aspectual, au****ate, au****e, au****ious, biaspectual,
bispecific,
bispecificity, cir****spect, cir****spection, cir****spective, conspecific, conspecificity...
